| Structure |
Chemical Name |
CAS |
MF |
 |
Ertapenem Impurity 2 |
|
|
|
|
Febuxostat Impurity 68 |
|
|
|
|
Indacaterol Impurity 9 |
|
|
 |
Olanzapine Impurity 22 |
|
C17H20N4S |
 |
Olopatadine Impurity 9 |
680579-52-6 |
C39H36Br2P2 |
 |
Oseltamivir Impurity 59 |
2485836-60-8 |
C12H22N2O3 |
|
|
Palbociclib Impurity 36 |
|
|
|
|
Regorafenib Impurity 34 |
|
|
|
|
Rosuvastatin Impurity 47 |
|
|
 |
Sildenafil Impurity 36 |
|
C25H27N3O5 |
|
|
Sunitinib Impurity 4 |
|
|
|
|
Tafluprost Impurity 11 |
|
|
|
|
Tazobactam Impurity 4 |
|
|
|
|
Ticagrelor Impurity 103 |
|
|
|
|
Ticagrelor Impurity 94 |
|
|
|
|
Tofacitinib Impurity 119 |
|
|
|
|
Trelagliptin Impurity 26 |
|
|
|
|
Trelagliptin Impurity 31 |
|
|
|
|
Caspofungin impurity E |
|
|
|
|
Erythromycin Impurity C |
|
|
|
|
Itraconazole iMpurity 4 |
|
|
|
|
Azacitidine Impurity 3 |
|
|
|
|
Ozagrel Impurity 2 |
|
|
|
|
Olaparib Impurity 22 |
|
|
 |
Irbesartan Impurity 14 |
133690-91-2 |
C25H28N6O |
 |
Febuxostat Impurity 25 |
1643131-89-8 |
C17H20N2O4S |
 |
Pregabalin Impurity 3 |
1928754-83-9 |
C12H22O3 |
|
|
Bosutinib Impurity 6 |
|
|
|
|
Ticagrelor Impurity 49 |
2376278-80-5 |
|
|
|
Edoxaban Impurity 14 |
|
|
 |
Indacaterol Impurity 3 |
2250243-41-3 |
C26H32N2O3 |
|
|
Canagliflozin Impurity 11 |
|
|
|
|
Oseltamivir Impurity 22 |
|
|
|
|
Riociguat IMpurtiy B |
|
|
|
|
Silodosin Impurity C |
|
|
 |
Dexmedetomidine-025 |
2250242-52-3 |
C20H22N2 |
|
|
pranoprofen impurity 15 |
|
|
 |
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
|
|
Metronidazole impurity A |
|
|
|
|
Sulpiride Impurity 6 |
|
|
|
|
Cefminox Impurity A |
|
|
|
|
Cefminox Impurity F |
|
|
 |
(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ& |
120570-09-4 |
C15H24Cl2N2 |
![CLOPIDOGREL RELATED COMPOUND B (20 MG) (METHYL(+/-)-(O-CHLOROPHENYL)-4,5-DIHYDROTHIE-NO[2,3-C]PYRIDINE-6(7H)-ACETATE, HYDROCHLORIDE)](/CAS/GIF/144750-52-7.gif) |
CLOPIDOGREL RELATED COMPOUND B (20 MG) (METHYL(+/-)-(O-CHLOROPHENYL)-4,5-DIHYDROTHIE-NO[2,3-C]PYRIDINE-6(7H)-ACETATE, HYDROCHLORIDE) |
144750-52-7 |
C16H16ClNO2S.ClH |
![VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE)](/CAS/GIF/1794-55-4.gif) |
VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE) |
1794-55-4 |
C26H37ClN2O4 |
 |
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C38H49NO11S |
 |
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
 |
Mupirocin iMpurity 5 |
|
C26H44O9 |
 |
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
 |
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
 |
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
 |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
 |
tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
|
C37H43FN2O5 |
 |
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
 |
Nifedipine impurity 06 |
|
C19H22N2O6 |
|
|
Moxifloxacin Impurity 10 |
|
|
|
|
Ticagrelor Impurity 11 |
|
|
|
|
Parecoxib Impurity 18 |
|
|
|
|
Apixaban Impurity 34 |
|
|
|
|
Teneligliptin Impurity 9 DiHCl |
|
|
|
|
Pramipexole Impurity Z2 |
|
|
![monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate)](/CAS/20200119/GIF/CB05441222.gif) |
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
|
|
Aprepitant iMpurity 40 |
|
|
|
|
Aprepitant iMpurity43 |
|
|
 |
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
|
|
Afatinib Impurity ODQ |
|
|
|
|
Afatinib Impurity ODQ |
|
|
 |
Afatinib Impurity QJJ |
2323570-72-3 |
C24H27ClFN5O4 |
|
|
Afatinib Impurity QJJ |
2323570-72-3 |
C24H27ClFN5O4 |
 |
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
|
|
Landiolol impurity U |
|
|
|
|
Teneligliptin Impurity 15 |
|
|
|
|
Nicergoline EP Impurity I |
|
|
![Carbamic acid, N-[(4-methylphenyl)sulfonyl]-](/CAS/20200331/GIF/107628-27-3.gif) |
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
 |
9H-Purin-6-amine, 9-(2-chloropropyl)- |
50615-40-2 |
C8H10ClN5 |
|
|
Hyoscine Butylbromide EP Impurity G |
|
|
 |
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
 |
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
 |
Brexpiprazole Impurity 77 |
1783311-11-4 |
C12H14N2S |
 |
(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol |
114218-35-8 |
C15H26ClNO3 |
|
|
Recombinant Endo Beta-N-Acetylglucosaminidase (ENGASE) |
|
|
 |
1-Pentanone, 1-(2-hydroxy-5-methylphenyl)- |
150033-77-5 |
C12H16O2 |
 |
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
 |
PLSQ-001 TM4-QJ |
1227162-74-4 |
C18H24N2O2 |
 |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C11H17NO4 |
![2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3)](/CAS/20211123/GIF/2095467-43-7.gif) |
2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3) |
2095467-43-7 |
C15H20ClN3 |
 |
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
|
|
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
 |
Droxidopa Impurity 4 |
55382-14-4 |
C31H29NO7 |
|
|
(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol |
|
|
|
|
Dapagliflozin Impurity (MW:423Da) |
|
|
|
|
Ramipril - Isomer Impurity 1 |
|
|
|
|
Aripiprazole peroxide degradation Impurity (MW:480Da) |
|
|
|
|
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
|
|
Dapoxetine Impurity 40 |
|
|
|
|
Doxofylline Impurity 15 |
|
|
|
|
Iohexol Impurity 10 |
|
|
|
|
Salbutamol Impurity 40 |
|
|
|
|
Benzylpenicillin EP(CP) Impurity F |
|
|